3 results  1 of 1 

1 Clinical Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer Patients with Liver Metastases: A Network Meta-Analysis of Nine Randomized Controlled Trials
Qing Yin, Longguo Dai, Ruizhu Sun, Ping Ke, Liya Liu, Bo Jiang
Cancer Res Treat.2022;54(3):803-816.   Published online 2021 October 25     DOI: http://dx.doi.org/10.4143/crt.2021.764
      
2 The Effect of Mitomycin-c, Vinblastine, and Cisplatin(MVP) Combined Chemotherapy in Non-Small Cell Lung Cancer
Young Woo Kim, Neung Hwa Park, Sang Keun Ji, Hyun Muck Choi, Sin Hwa Lee, Keum Hee Lee, Tae Won Jang, Maan Hong Jung
Tuberc Respir Dis.1995;42(1):76-83.   Published online 2016 March 29     DOI: http://dx.doi.org/10.4046/trd.1995.42.1.76
      
3 Gemcitabine Plus Vinorelbine as Second-line Chemotherapy of the Patients of Previously Treated Non-small Cell lung Cancer: Phase II Trial
Pil Soon Jang, Hyun Mo Kang, Jeong Eun Lee, Seon Jung Kwon, Jin Young An, Yun Sun Lee, Sung Soo Jeong, Ju Ock Kim, Sun Young Kim
Tuberc Respir Dis.2005;58(4):344-351.   Published online 2005 April 30     DOI: http://dx.doi.org/10.4046/trd.2005.58.4.344
      

 1 of 1